Table 1.
Antimicrobial activities of various antimicrobial agents against 301 E. coli and K. pneumoniae isolates.
Figure 1.
A, K2821 K. pneumoniae (KPC-2 carbapenemase producer). B, 08-438 E.coli. C, 08-97 K. pneumoniae. D, E. coli ATCC 25922.
Table 2.
Distribution of ESBL genes among the 301 E. coli and K. pneumoniae isolates.
Table 3.
The characteristics of the 10 false-positive isolates by MHT.
Figure 2.
1. E.coli ATCC 25922, 2. 08-309 E.coli, 3. 08-318 E.coli, 4. 08-438 E.coli, 5. E.coli ATCC 25922, 6. 08-547 E.coli, 7. 08-1002 E.coli, 8. 08-1039 E.coli, M. Marker.
Figure 3.
1. K1933 K. Pneumoniae (Sensitive to cefazolin, no ESBL and carbapenemase producer), 2. 08-97 K. Pneumoniae, 3. 08-1105 K. Pneumoniae, 4. 08-466 K. Pneumoniae, 5. 08-893 K. Pneumoniae, M. Marker.